about
Role of progesterone in nicotine addiction: evidence from initiation to relapse.Progesterone effects on subjective and physiological responses to intravenous nicotine in male and female smokersEffects of hormone therapy on cognition and moodPrescribing menopausal hormone therapy: an evidence-based approachThe effects of progesterone pretreatment on the response to oral d-amphetamine in Women.Counseling postmenopausal women about bioidentical hormones: ten discussion points for practicing physicians.Progesterone improves cognitive performance and attenuates smoking urges in abstinent smokers.Effects of different hormone therapies on breast pain in recently postmenopausal women: findings from the Mayo Clinic KEEPS breast pain ancillary studyThe effects of oral micronized progesterone on smoked cocaine self-administration in women.Progesterone synthesis in the nervous system: implications for myelination and myelin repair.Micronized Organic Magnesium Salts Enhance Opioid Analgesia in Rats.Vaginal progesterone in risk reduction of preterm birth in women with short cervix in the midtrimester of pregnancyRationale and design of the Kronos Early Estrogen Prevention Study (KEEPS) and the KEEPS Cognitive and Affective sub study (KEEPS Cog)The Utrogestan and hMG protocol in patients with polycystic ovarian syndrome undergoing controlled ovarian hyperstimulation during IVF/ICSI treatments.The rebirth of progesterone in the prevention of preterm labor.Dydrogesterone use in early pregnancy.Transdermal estradiol and oral or vaginal natural progesterone: bleeding patterns.Effect of micronized progesterone on bone turnover in postmenopausal women on estrogen replacement therapy.Exogenous progesterone attenuates the subjective effects of smoked cocaine in women, but not in men.Comparison of neonatal outcomes and live-birth defects after progestin-primed ovarian stimulation versus conventional ovarian stimulation for in vitro fertilization: A large retrospective cohort study
P2860
Q24630902-9062DA56-083F-4D36-B8FF-776527B7CBC9Q24649003-DCFE320C-3298-46C2-9988-CAE3F03568C1Q26865143-F3417B0C-535C-4148-BBCF-B44A37F9DB5FQ27022920-46AB5BA7-175D-415D-964F-F436CC41C1CAQ34043965-D72ED014-1F6F-47A7-8029-4E9FA6D20CD3Q34169103-8031CCCA-D8E2-473C-83AA-6379355B3547Q34329990-EF0C6A4B-C173-415C-ACD8-394905DAA168Q34330784-C3E0518A-5949-443D-B916-153BB71C9769Q34579501-431F8CEC-FD2C-42D2-8DB1-7FE85855A343Q35743169-A80EFE4B-0CB3-41EA-88AF-D6E077057B80Q36177137-98666487-502B-48C6-811D-8C04973ECC1CQ36311625-66BD5B68-5476-4350-8545-F7D32DD4A10DQ37063691-CD918068-8037-4FFC-9408-A9D2C2E981C8Q37116869-C3881560-9239-497D-B135-C69A59E8F3B8Q38093767-9B33E144-6A7B-400D-A55E-C9348C815916Q38708094-BF4F2821-6F2D-49B3-8A13-94C9E8DCDB1EQ43006536-161D9F22-0FD4-4475-A13D-A6E7876EA42FQ44510497-40EA3818-1BB7-405A-917E-3E4585FC666AQ46701585-02BAAA9D-FD97-4CC5-AAB2-90EAFC93A2FDQ58706551-0192CC46-7EDE-48BF-BF3C-F86EC76FBC47
P2860
description
1999 nî lūn-bûn
@nan
1999 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Oral micronized progesterone.
@ast
Oral micronized progesterone.
@en
Oral micronized progesterone.
@nl
type
label
Oral micronized progesterone.
@ast
Oral micronized progesterone.
@en
Oral micronized progesterone.
@nl
prefLabel
Oral micronized progesterone.
@ast
Oral micronized progesterone.
@en
Oral micronized progesterone.
@nl
P1476
Oral micronized progesterone.
@en
P2093
de Lignières B
P304
41-60; discussion 1-2
P356
10.1016/S0149-2918(00)88267-3
P577
1999-01-01T00:00:00Z